Below All Moving Averages and Now at Lower Circuit: Venus Remedies Ltd Loses 5.0% in a Single Session

Circuit Event and Unfilled Supply

The stock, trading in the EQ series, hit its lower circuit at Rs 999.55, marking a 4.98% decline within the 5% price band permitted for the day. This price band capped the maximum daily loss, effectively freezing trading at the floor price. The total traded volume was 69,013 shares, with a turnover of ₹6.95 crore. Despite this turnover, the price remained locked at the lower circuit, indicating that sellers overwhelmed demand to the point where the exchange's circuit breaker intervened. This unfilled supply scenario is typical for lower circuit events, especially in micro-cap stocks like Venus Remedies Ltd, where liquidity constraints exacerbate exit difficulties. Venus Remedies Ltd’s market capitalisation stands at ₹1,343 crore, placing it firmly in the micro-cap segment where such circuit locks can persist for multiple sessions.

Delivery and Volume Analysis

Delivery volumes on 22 Apr 2026 rose by 15.66% compared to the 5-day average, reaching 38,520 shares. On a lower circuit day, rising delivery volume is a critical indicator — it signals genuine liquidation by holders rather than speculative short-selling. This means that actual shareholders are offloading their positions, completing delivery of shares sold, which points to capitulation or forced selling rather than intraday trading activity. The total traded volume, while mechanically limited by the circuit lock, was lower than usual, but the weighted average price was closer to the day’s low, reinforcing the dominance of selling pressure. Venus Remedies Ltd’s delivery data on this day thus reflects a meaningful exit by holders — does this surge in delivery volume mark a capitulation point or could selling pressure persist?

Intraday Price Action

The stock opened at Rs 1,057.00 and steadily declined throughout the session, closing at Rs 999.75. This intraday swing of approximately 5.4% reflects a gradual but persistent sell-off rather than a sudden crash. The weighted average price being closer to the low suggests that most trades occurred near the circuit floor, with sellers unable to find buyers at higher levels. This pattern indicates that the selling pressure was sustained and that demand was absent from the outset, rather than a late-session capitulation. does the intraday price arc suggest exhaustion or a continuation of downward momentum?

Moving Averages and Trend Context

Technically, Venus Remedies Ltd remains below its 5-day moving average, confirming short-term weakness. However, it is still trading above its 20-day, 50-day, 100-day, and 200-day moving averages, indicating that the longer-term trend has not yet fully turned bearish. This mixed technical picture suggests that while immediate selling pressure is strong enough to trigger a circuit lock, the stock has not yet broken down through all key support levels. The 5-day moving average acting as resistance may be a focal point for short-term traders, but does the technical profile of Venus Remedies Ltd show any nearby support, or is more downside likely?

Liquidity and Exit Risk

With a market capitalisation of ₹1,343 crore, Venus Remedies Ltd is classified as a micro-cap stock. Its liquidity profile is moderate, with a trade size of approximately ₹0.11 crore based on 2% of the 5-day average traded value. While this suggests some capacity for trading, the lower circuit lock highlights a critical exit risk: sellers who wish to exit positions at these levels face significant difficulty due to the absence of buyers. This liquidity squeeze can prolong circuit locks and amplify downward pressure, especially in micro-cap stocks where market depth is limited. The unfilled supply at Rs 999.75 is a stark reminder of the challenges faced by holders attempting to liquidate. With unfilled sell orders and near-zero demand, how deep is the exit problem for Venus Remedies Ltd and what would need to change for normal trading to resume?

Fundamental Context

Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, a space that often experiences volatility linked to regulatory developments and sector-specific news flows. While the stock has underperformed its sector by 6.81% on the day, the broader Sensex declined by only 0.64%, underscoring the stock-specific nature of this sell-off. The recent two-day gain reversal suggests that the current weakness is a correction rather than a sector-wide trend. However, the micro-cap status and liquidity constraints add layers of complexity to the stock’s price action.

Conclusion: Severity and Liquidity Caveats

The 5.0% single-day loss culminating in a lower circuit lock for Venus Remedies Ltd reflects a session dominated by genuine selling pressure, as evidenced by rising delivery volumes and a weighted average price near the circuit floor. The intraday price arc from Rs 1,057 to Rs 999.55 shows a steady decline rather than a sudden crash, while the technical positioning below the 5-day moving average confirms short-term weakness. The micro-cap classification and moderate liquidity profile raise concerns about exit risk, as sellers face limited demand at these levels. The circuit breaker has effectively frozen the price, but it has also trapped sellers who arrived too late to exit. After a 5.0% single-day loss at lower circuit, is Venus Remedies Ltd approaching oversold territory or does the selling pressure have further to run? The complete analysis weighs the data.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today